Cassava Sciences Inc vs iShares Core S&P 500 ETF — how do they compare? Cassava Sciences Inc trades at $0.97 (market cap $47.75M), while iShares Core S&P 500 ETF trades at $776.3. The key difference: iShares Core S&P 500 ETF is trading nearer its 52-week high, Cassava Sciences Inc nearer its low. Which is the better fit depends on your goals.
| FLNA | IVV | |
|---|---|---|
Market Cap | $47.75M | — |
Sector | Health | Broad Market / Factor |
52-Week High | $4.64 | $776.81 |
52-Week Low | $0.87 | $634.93 |
Enterprise Value | -$34.93M | — |
Trailing returns across standard periods
Latest headlines on both assets
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →IVV tracks the performance of the S&P 500 Index, offering low-cost exposure to 500 of the largest US companies. It is a cornerstone for long-term investors seeking broad growth in the US stock market.
Read more on IVV →